Gene: NDUFB10
Official Full Name: NADH:ubiquinone oxidoreductase subunit B10provided by HGNC
Gene Summary: Predicted to enable NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial respiratory chain complex I assembly. Located in mitochondrion. Part of mitochondrial inner membrane and respiratory chain complex I. Implicated in nuclear type mitochondrial complex I deficiency 35. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36417 | NDUFB10 Knockout cell line (HeLa) | Human | NDUFB10 | 1:3~1:6 | Negative | Online Inquiry |
KO36418 | NDUFB10 Knockout cell line (HCT 116) | Human | NDUFB10 | 1:2~1:4 | Negative | Online Inquiry |
KO36419 | NDUFB10 Knockout cell line (HEK293) | Human | NDUFB10 | 1:3~1:6 | Negative | Online Inquiry |
KO36420 | NDUFB10 Knockout cell line (A549) | Human | NDUFB10 | 1:3~1:4 | Negative | Online Inquiry |
NDUFB10 Gene Knockout Cell Lines represent a pivotal advancement in cellular research, specifically designed to study the effects of the NDUFB10 gene on mitochondrial function and energy metabolism. NDUFB10 encodes a crucial subunit of the mitochondrial NADH dehydrogenase complex (Complex I), which plays a vital role in the oxidative phosphorylation pathway, responsible for ATP production. By employing CRISPR/Cas9 technology, these knockout cell lines allow researchers to observe the phenotypic and functional consequences of NDUFB10 deficiency, thereby elucidating its role in various metabolic disorders and mitochondrial diseases.
The primary function of NDUFB10 Gene Knockout Cell Lines is to facilitate the analysis of mitochondrial dysfunction that can lead to insights into conditions such as Parkinson's disease, diabetes, and other neurodegenerative disorders. By systematically studying these cell lines, researchers can investigate the downstream impacts of mitochondrial impairment, including altered reactive oxygen species (ROS) production and shifts in cellular metabolism. This ability to model human disease at the cellular level is vital for developing novel therapeutic approaches.
In comparison to alternative methods, such as pharmacological inhibition or the use of siRNA for gene silencing, NDUFB10 Gene Knockout Cell Lines provide a stable, heritable knockout of the target gene, ensuring reproducibility and longevity in experimental results. They offer unparalleled precision in genetic manipulation, which is essential for rigorous scientific inquiry.
Researchers and clinicians will find these knockout cell lines invaluable for their applications in drug discovery, toxicology assessments, and basic mitochondrial biology studies, ultimately leading to the identification of potential biomarkers and therapeutic targets. Our company has extensive expertise in developing high-quality genetic models, ensuring that each product is optimized for performance and reliability. Thus, NDUFB10 Gene Knockout Cell Lines align seamlessly with our commitment to advancing scientific research and enhancing the understanding of complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.